CRNX Crinetics Pharmaceuticals In

held by 1 manager in Q2 2024

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.49%	6 mo	—	$14M	309,000

Search